BUZZ — Keymed Biosciences hits near 3 — month high on product revenue growth
* Shares of Keymed Biosciences jump 12.5% to HK$85.7, their highest level since July 24 * Stock of biological therapies developer on course for biggest one-day pct rise since June 29 after three consecutive sessions of falls * Keymed recorded about 660 million yuan ($98.63 million) in revenue from product Kangyueda dur